Latest Headlines

31. MilliporeSigma Announces Siren Biotechnology As Winner Of Its North American Advance Biotech Grant 6/4/2024

    MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, announced today that Siren Biotechnology has been selected as the North American winner of its 13th Advance Biotech Grant Program. The biotechnology startup, which is headquartered in San Francisco, California, USA, was selected for the development of its universal adeno-associated virus (AAV) immuno-gene therapy for cancer.

32. Ingersoll Rand Closes On ILC Dover and Announces Acquisition Of Three Additional Companies 6/4/2024

    Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and industrial solutions, has closed on the previously announced acquisition of ILC Dover (“ILC”) and has acquired Complete Air and Power Solutions (“CAPS”), Del PD Pumps & Gear Pvt Ltd. (“Del Pumps”), and Fruvac Ltd. (“Fruitland Manufacturing”) for a combined purchase price of approximately $150 million.

33. Cleanroom Leader AES Clean Technology Announces New CEO 5/31/2024

    A leading provider of high-performance cleanroom facilities, AES Clean Technology, has appointed Chris Miller as Chief Executive Officer.

34. Innovation And Automation Are Driving Forces Behind Next Generation Cell Therapy Manufacturing Platform From Cytiva 5/30/2024
35. Honeywell Announces Exhibition Schedule For June 2024 5/24/2024

    Honeywell will be showing how a full suite of digital manufacturing technologies in automation, digitalization, and quality management helps life science manufacturing companies improve product quality, drive business outcomes, and innovate from product to patient.  Join experts at 3 separate events coming up in June.

36. CAI And Fedegari Group Announce New Partnership To Deliver Turnkey Sterilization Solutions To Drug Manufacturers 5/24/2024

    CAI, a global company that provides technical, operational consulting, and project management services, today announced its strategic partnership with Fedegari Group, a manufacturer and service provider of high-performance sterilization systems.

37. Blackstone Life Sciences Launches Uniquity Bio To Develop Novel Medicines In Immunology & Inflammation 5/15/2024

    Blackstone (NYSE:BX) today announced the launch of the Blackstone Life Sciences (“Blackstone”) portfolio company Uniquity Bio, a clinical-stage drug development company focused on immunology and inflammation.

38. Ribobay Pharma Boosts CRDMO Offerings With Cytiva's First FlexFactory Platform For Oligonucleotides 5/15/2024

    Ribobay Pharma, a leading Chinese biopharmaceutical contract research, development, and manufacturing organization (CRDMO) and a spin-off company of General Biol (Anhui) Co., Ltd, will provide cGMP-level oligonucleotide (oligo) CRDMO services to the world using Cytiva’s first FlexFactory platform for oligo manufacturing.

39. CAI Announces, “Impacting Manufacturing Operations Through Quality Risk Management And Contamination Control Strategy” Event For June 10 In Maryland 5/8/2024

    Join CAI on Monday, June 10th for an insightful discussion on Impacting Manufacturing Operations through Quality Risk Management and Contamination Control Strategy. Collaborate with industry experts and colleagues. Together we'll dive into how recent regulatory guidance is directly impacting day to day operations and how others are assessing, and implementing their CCS utilizing QRM.

40. MilliporeSigma Expands Its Optimized VirusExpress® Platform For Lentiviral Vectors, Further Enhancing Quality And De-Risking Cell And Gene Therapy Manufacturing 5/8/2024

    MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, is pleased to announce the expansion of its VirusExpress^® platform used in the development and manufacturing of lentiviral vectors.